Clinical Trials Logo

Clinical Trial Summary

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02225912
Study type Interventional
Source BioHealth Technologies Inc.
Contact
Status Completed
Phase Phase 4
Start date February 2005
Completion date May 2005

See also
  Status Clinical Trial Phase
Completed NCT02451163 - DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly Phase 2
Recruiting NCT01971112 - Nutritional Intervention and Respiratory Infections in Older Subjects N/A
Completed NCT01717534 - Children Immune Functions N/A
Completed NCT01728090 - Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections Phase 4
Completed NCT00235703 - Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART) N/A
Completed NCT02232711 - Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting N/A
Completed NCT01731392 - Children Immune Functions(2) N/A
Withdrawn NCT00773435 - Effects of Echinacea in Children N/A
Completed NCT03464279 - Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections N/A
Completed NCT01586962 - Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI Phase 3
Completed NCT01576809 - Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI) Phase 3
Completed NCT00611195 - Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI Phase 4